Back Business
-
Briefly
HYDERABAD: Aurobindo Pharma has announced the receipt of tentative approval for its Zidovudine 300 mg tablets from the U.S. Food and Drug Administration. This makes the company qualify under the President's Emergency Plan for AIDS relief (PEPFAR) program for Zidovudine 300 mg.
© Copyright 2000 - 2009 The Hindu |